Two studies recently published in Veterinary and Animal Science have raised questions about the welfare of Atlantic salmon during thermal delousing treatments. Results of the studies found that exposure to warm water caused a highly aversive reaction that was likely attributed to the sudden change in temperature, not the presence of other fish or manual handling.
30 March 2020
With the global and local COVID-19 situation changing rapidly, we hope you are all keeping safe and remaining positive during these challenging times. Our top priority at AQUI-S New Zealand Ltd. is the health and wellbeing of our people, their families, and our community.
In order to support the containment of COVID-19, particularly through eliminating the risk of community transmission, AQUI-S New Zealand Ltd. has chosen to shut our offices and production facility in Lower Hutt for the recommended 4-week period, ending 22nd April 2020. During this time AQUI-S staff will be working remotely and can be contacted by phone and email.
If you have any questions or concerns, please don’t hesitate to get in touch with us directly.
Kia Kaha - Be Strong,
Nic Paton - Technical & Marketing Manager
The recent merger of Scan Aqua with MSD Animal Health is sure to provide some exciting opportunities in the Norwegian and European aquaculture markets. MSD Animal Health offers one of the industry's most innovative product portfolios, from disease prevention to disease treatment and control. MSD Animal Health's philosophy around humane treatment of animals through welfare considered practices is equal to that of AQUI-S New Zealand’s, making them ideal partners moving forward.
The role of AQUI-S NZ Ltd. will remain unchanged with our primary focus being the production of high-quality veterinary GMP anaesthetics and superior support to both end-users and distributors alike.
Please don’t hesitate to contact MSD Animal Health or AQUI-S New Zealand Ltd today to see how we can work for you.
We are excited to announce the appointment of Veterquimica S.A. as the new distributor for AQUI-S® products in Chile.
Veterquimica S.A. has more than 45 years experience in the market and has business branches in Animal Health, Animal Nutrition, Hygiene and Biosecurity, and Service Laboratory. Within the aquaculture segment, Veterquimica S.A. is actively developing and selling products for fish health, fish nutrition and farm biosecurity/hygiene. This makes Veterquimica S.A. an ideal partner for our AQUI-S aquatic sedative.
Bathing salmon in freshwater is a commercially important tool for the control of various diseases including Sea Lice and Amoebic gill disease (AGD).
These treatment operations are well known to be stressful to the fish which in turn causes significant quality issues during and post-treatment. A recent study conducted in Norway has further highlighted exactly how stressful these procedures are in terms of cortisol release. If you would like more information from this study or other related work, contact AQUI-S NEW ZEALAND Ltd. directly.